Idenix

Merck “More Formidable” Competitor for Gilead, But Still Years Away
Barron's
Mon, 06/9/14 - 11:58 am
Merck
Gilead Sciences
Idenix
M&A
hepatitis C
Achillion Pharma Might be Next Hep C Takeout Target
TheStreet.com
Mon, 06/9/14 - 09:40 am
Achillion
hepatitis C
M&A
JNJ
AbbVie
Merck
Idenix
Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C
Forbes
Mon, 06/9/14 - 09:24 am
Merck
hepatitis C
M&A
Idenix
Merck to Buy Hepatitis-Drug Maker Idenix
Bloomberg
Mon, 06/9/14 - 11:59 am
Idenix
Merck
M&A
hepatitis C
Idenix's Q1 Loss Widens
Yahoo/Zacks.com
Mon, 05/5/14 - 09:56 am
earnings
Idenix
The Baupost Group ups its stake in Idenix Pharmaceuticals
Yahoo/Market Realist
Sat, 03/15/14 - 10:01 am
Idenix
Gilead's hot-selling Sovaldi draws more patent attacks
Fierce Pharma
Fri, 03/14/14 - 11:15 am
Sovaldi
Idenix
Merck
Roche
hepatitis C
patents
Gilead Sciences
The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Mon, 02/24/14 - 11:15 am
Spectrum Pharmaceuticals
Dendreon
Achillion
Ziopharm
Intrexon
Arena Pharmaceuticals
Idenix
Synta Pharmaceuticals
Sarepta Therapeutics
Myriad Genetics
3 Biotech Stocks to Bet on this Earnings Season
Yahoo/Zacks.com
Thu, 02/20/14 - 08:50 am
earnings
Medivation
United Therapeutics
Idenix
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised
TheStreet.com
Tue, 01/28/14 - 11:17 am
Idenix
Pharma CEOs
Gilead Sciences
hepatitis C
Ron Renaud
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wed, 01/22/14 - 08:41 am
Teva Pharmaceuticals
M&A
Idenix
Insmed
NuPathe
InterMune
Puma Biotechnology
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
Idenix fires off a shot in patent battle over Gilead's sofosbuvir
Fierce Biotech
Mon, 12/2/13 - 05:04 pm
Idenix
Gilead
sofosbuvir
hepatitis C
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sun, 10/13/13 - 12:06 pm
Ariad
Acadia
Idenix
Janssen Purchase Doesn't Change Case For Idenix
Seeking Alpha
Thu, 10/10/13 - 06:17 pm
Janssen
Idenix
IDX719
These 2 Hepatitis-C Drug Developers Are Getting Left in the Dust
Motley Fool
Mon, 09/30/13 - 10:41 am
hepatitis C
Vertex Pharmaceuticals
Incivek
sovaprevir
Achillion
IDX184
IDX320
Idenix
Idenix Pharmaceuticals: Potential Multi-Bagger Means Little Risk/High Reward
Seeking Alpha
Wed, 07/31/13 - 10:13 am
Idenix
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Sat, 07/20/13 - 11:26 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C
Bristol-Myers Squibb
Idenix

Pages